Ambien is the brand name for zolpidem, a prescription sleep drug. The FDA’s label calls it a GABA-A receptor positive modulator. It is approved for the short-term treatment of insomnia marked by difficulty falling asleep, and it is a Schedule IV controlled substance [1]. It can produce tolerance, physical dependence and withdrawal. The label records postmarketing reports of abuse, dependence and withdrawal [1]. It also carries the FDA’s most prominent warning, a boxed warning, for something most people have never heard of. That is complex sleep behaviors, in which a person drives, cooks, eats or makes calls while not fully awake [1].
This page is the hub for Ambien on this site. It covers what the drug is and whether it is addictive. It covers the boxed warning, the side effects, and the combinations that turn a sleeping pill into an emergency. It covers withdrawal in outline, how long the drug stays in the body in the only form a federal source supports, what an overdose looks like, and how dependence is treated. It names no amount and no schedule. Our hub on prescription drug addiction covers the wider class.
Zolpidem belongs to the group NIDA calls non-benzodiazepine sleep medications, or z-drugs. Eszopiclone and zaleplon are the others. NIDA explains that they have a different chemical structure from benzodiazepines but act on the same GABA type A receptors in the brain [3]. Most central nervous system depressants work the same way. They increase activity at receptors for GABA, an inhibitory messenger in the brain. That increases inhibition of brain activity, which produces the drowsy or calming effect that is useful for anxiety or sleep disorders [3]. MedlinePlus puts it in one line. Zolpidem is a sedative-hypnotic that works by slowing activity in the brain to allow sleep [2].
The label’s approval is narrow. Ambien is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation [1]. MedlinePlus lists the forms: a tablet, an extended-release tablet, a tablet placed under the tongue, and an oral spray [2]. How long it is used, how much, and how it is stopped are prescriber matters. None of that is repeated here.
The label answers this with four definitions, and they are worth keeping apart. Tolerance is a state of adaptation in which exposure to a drug produces changes that reduce one or more of its effects over time [1]. Physical dependence is a state of adaptation shown by a specific withdrawal syndrome. That syndrome appears when the drug is stopped abruptly, reduced rapidly, or blocked by an antagonist [1]. Abuse is misuse of the drug for non-medical purposes, often with other psychoactive substances [1]. Addiction is a primary, chronic, neurobiological disease. It is marked by impaired control over drug use, compulsive use, continued use despite harm, and craving. The label adds that it is treatable, and that relapse is common [1].
Then it says where Ambien sits. Use of Ambien may lead to physical or psychological dependence. The risk increases with the amount and the duration of treatment [1]. The risk of abuse and dependence is greater in people with a history of alcohol or drug problems. The label says the drug should be used with extreme caution in that group [1]. There have been postmarketing reports of abuse, dependence and withdrawal with zolpidem [1].
NIDA gives the class view, with its hedges intact. Z-drugs are thought to have fewer side effects and less risk of dependence than benzodiazepines [3]. But their use is less well studied, and certain indicators have raised concern about their misuse potential as well [3]. NIDA describes the road in. During the first few days on a depressant a person usually feels sleepy and uncoordinated. Those effects fade as tolerance develops. Longer use may require more of the drug for the same effect. Continued use can lead to dependence, and to withdrawal when use is reduced or stopped [3]. MedlinePlus’s warning to the consumer is plainer. Zolpidem may be habit forming. Do not take more of it, take it more often, or take it for longer than your doctor prescribed [2].
So the answer to “is it addictive” is yes, in the label’s own terms. It is also less often addictive than the drugs it was designed to replace, in NIDA’s. Both halves are true. Our page on benzodiazepines covers the class Ambien is usually compared with.
The boxed warning is the first thing on the label, and it is not about addiction. Complex sleep behaviors may occur after the first or any later use of Ambien. The label names sleep-walking, sleep-driving, and other activities while not fully awake [1]. Patients can be seriously injured or injure others during these behaviors. Such injuries may result in a fatal outcome [1]. The label’s other examples are preparing and eating food, making phone calls and having sex. It notes that patients usually do not remember these events [1].
Two details change how people should read the warning. Postmarketing reports have shown that complex sleep behaviors may occur with Ambien alone, at the amounts the label recommends, with or without alcohol or other depressants [1]. And the label’s instruction is absolute. Discontinue Ambien immediately if a patient experiences a complex sleep behavior [1].
MedlinePlus says the same to the person taking it. Some people who took zolpidem got out of bed and drove their cars, prepared and ate food, had sex, made phone calls, or sleep-walked while not fully awake. Afterwards they could not remember it [2]. Its instructions are three. Tell your doctor if you have ever had an unusual sleep behavior on zolpidem. Make sure your family or caregiver knows these symptoms are serious and will call your doctor if they occur. And stop taking zolpidem and call your doctor right away if you find out you have been driving or doing anything else unusual while asleep [2].
Like other sedative-hypnotics, Ambien depresses the central nervous system. The label says taking it with other depressants increases the risk of central nervous system depression, and it names benzodiazepines, opioids, tricyclic antidepressants and alcohol [1]. It tells prescribers to advise patients not to use Ambien if they drank alcohol that evening or before bed [1]. It flags opioids separately, because that combination may increase the risk of respiratory depression [1].
The label’s next warning is about the morning after. The risk of next-day impairment, including impaired driving, is higher if Ambien is taken with less than a full night of sleep remaining, if more than the prescribed amount is taken, or if it is taken with other depressants [1]. It also describes abnormal thinking and behavior changes reported with sedative-hypnotics including Ambien. These include decreased inhibition, aggressiveness or extroversion that seems out of character, bizarre behavior, agitation, depersonalization, and visual and auditory hallucinations [1].
MedlinePlus’s overdose list is the short version of what too much of a depressant does: drowsiness, coma, and slowed breathing or heartbeat [2]. A person who has taken Ambien with alcohol, an opioid or another sedative and cannot be woken is not sleeping.
If someone is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Withdrawal is what physical dependence looks like when the drug stops. The label describes it for the whole class. Sedative-hypnotics have produced withdrawal signs and symptoms after abrupt discontinuation. These range from mild dysphoria and insomnia to a syndrome that may include abdominal and muscle cramps, vomiting, sweating, tremors, convulsions and delirium [1]. For Ambien itself, the label lists the events reported in clinical trials after the drug was replaced with placebo, occurring within 48 hours of the last zolpidem. They were fatigue, nausea, flushing, lightheadedness, uncontrolled crying, vomiting, stomach cramps, panic attack, nervousness and abdominal discomfort [1]. It adds that these occurred at an incidence of 1 percent or less. It also says the available data cannot give a reliable estimate of how often dependence develops at the amounts the label recommends [1].
MedlinePlus writes the list for the person. Shakiness, lightheadedness, stomach and muscle cramps, nausea, vomiting, sweating, flushing, tiredness, uncontrollable crying, nervousness, panic attack, trouble falling or staying asleep, uncontrollable shaking of a part of the body, and, rarely, seizures [2]. It also names the thing people mistake for failure. You may have more trouble sleeping on the first night after you stop zolpidem than you did before you started it [2]. NIDA explains why. Depressants work by slowing the brain’s activity, so there can be a rebound effect when a person stops. That rebound can result in seizures or other harmful consequences [3].
The instruction in all three sources is the same. MedlinePlus: do not stop taking zolpidem without talking to your doctor, especially if you have taken it for longer than two weeks [2]. NIDA: someone thinking about stopping a central nervous system depressant, or suffering withdrawal after stopping, should speak with a physician or seek immediate medical treatment [3]. What none of them publishes, and this page does not either, is a day-by-day timeline for zolpidem withdrawal. Nor a schedule for reducing it. Nor a regimen for swapping it for another drug. The general shape of withdrawal symptoms across substances is on our overview page.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Treatment for Ambien dependence in Florida
The Recovery Village Umatilla is our campus in Umatilla, Florida, and its own page cards medical detox, inpatient treatment for substance abuse, inpatient rehab for mental health, partial hospitalization programming, outpatient programming and aftercare planning. Its inpatient mental health card says patients live onsite at the treatment center and then transition to outpatient care in the community, and whether a sleep problem, a dependence or both is the thing to treat first is decided at the assessment.
See treatment options in Florida Verify your insurance
The Recovery Village Umatilla is part of our family of treatment centers. See the Recovery Village Umatilla campus.
This is a question people ask about every drug. The honest answer is shorter than the answers found elsewhere.
What the label says. In the study the label reports, the mean elimination half-life of Ambien was about 2.5 hours, with a range of 1.4 to 4.5 hours across the tablets studied [1]. The drug is converted to inactive metabolites that leave the body mainly through the kidneys [1]. A half-life is how long it takes the amount in the blood to fall by half. It is a property of the drug. It is not a detection window, and the two should not be confused.
What the federal testing rules say. The federal workplace drug-testing rule at 49 CFR 40.85 lists nine analyte groups that laboratories must test for. Zolpidem is not among them [5]. SAMHSA’s table of urine detection periods in TIP 47 has rows for amphetamines, barbiturates, benzodiazepines, cocaine, cannabinoids, alcohol, opioids, methadone and others. It has no row for zolpidem [6]. Specialized tests for it exist. What a particular program, employer or court uses is the thing to ask them.
What a window would depend on, if you had one. SAMHSA says the time a substance can be detected in urine depends on many interacting factors. It names the drug’s chemical properties such as its half-life, its metabolism and excretion routes, the amount, route, frequency and length of use, the sensitivity and specificity of the assay, and individual variation [6]. That is why a single number for “how long” is a promise nobody can keep.
So this page prints no urine, blood or hair window for Ambien. No federal source it can cite gives one. Figures that circulate for zolpidem come from small studies at a set amount, and they are not this site’s to repeat.
The label’s description is direct. In overdose with zolpidem alone or with other depressants, impairment of consciousness ranging from somnolence to coma has been reported. So have cardiovascular or respiratory compromise, and fatal outcomes [1]. MedlinePlus lists the signs to watch for: drowsiness, coma, and slowed breathing or heartbeat [2].
What happens in a hospital is also on the label. General symptomatic and supportive measures are used [1]. Zolpidem’s sedative effect was shown to be reduced by flumazenil, so that drug may be useful [1]. In the same sentence the label warns that flumazenil may contribute to the appearance of neurological symptoms, including convulsions [1]. That is a decision for the emergency team. It is not a reason to wait.
MedlinePlus’s instruction for any overdose is to call 911 if the person has collapsed, had a seizure, has trouble breathing, or cannot be woken [2]. Zolpidem is a controlled substance. The label’s abuse section notes that in people with a history of drug problems, larger amounts produced effects similar, but not identical, to a benzodiazepine [1]. The numbers in that study are not on this page.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
NIDA’s guidance for this class is short and specific. Patients addicted to central nervous system depressants such as tranquilizers, sedatives and hypnotics should not attempt to stop taking them on their own. Withdrawal from these drugs can be severe and, for certain medications, potentially life-threatening [4]. Research on treating addiction to these drugs is sparse. But people who are dependent on them should undergo medically supervised detoxification, because the amount they take should be reduced gradually [4]. Inpatient or outpatient counseling can help a person through that process [4]. Cognitive-behavioral therapy works on a patient’s thinking, expectations and behaviors while building skills for coping with life stressors. NIDA says it has been used successfully to help people adapt to discontinuing benzodiazepines [4]. There are no FDA-approved medications for treating addiction to central nervous system depressants, though research is ongoing [4]. And because depressant misuse often occurs alongside alcohol or opioids, treatment should address the multiple addictions together [4].
That maps onto the levels of care in a plain way. Our page on medical detox explains what a supervised withdrawal is and who needs one. SAMHSA’s protocol is clear that detox is not substance abuse treatment and rehabilitation. A detox program is not designed to resolve the longstanding psychological, social and behavioral problems associated with alcohol and drug use [8]. Our guide to the levels of care sets out the five treatment levels that follow. Our page on inpatient rehab describes the most structured of them. Our page on outpatient rehab describes the lighter end. Our overview of the types of therapy and our page on cognitive behavioral therapy cover the counseling NIDA names. Our overview of medication-assisted treatment explains what those medications are for, and NIDA’s sentence above explains why none is approved for this class.
The problem underneath a zolpidem dependence is usually still there when the drug is gone. The person cannot sleep. The CDC’s general sleep habits are the ones a clinician will start with. Go to bed and get up at the same time every day. Keep the bedroom quiet, relaxing and cool. Turn off electronic devices before bedtime. Avoid large meals and alcohol before bed, and caffeine in the afternoon and evening. Exercise regularly [7]. The CDC’s rule for persistent problems is to talk to a healthcare provider, who can run tests including sleep studies [7]. Our page on sleeping without Ambien takes that question on its own. Our page on whether sleeping pills are safe covers the wider class.
The practical questions settle faster than people expect. Our page on how long rehab takes covers length of stay. Our page on how much rehab costs gives our own published price ranges by level of care. Our guide to insurance coverage covers what a plan decides. Our guide to the admissions process sets out what a program needs before it can give someone a date. Our page on what the rehab process is like walks through a stay, and our treatment center directory has a map you can browse by state.
In the label’s own terms, yes. Use of Ambien may lead to physical or psychological dependence. The risk rises with the amount and duration of treatment and with a history of alcohol or drug problems, and there are postmarketing reports of abuse, dependence and withdrawal. NIDA adds the class view: z-drugs are thought to carry less risk of dependence than benzodiazepines, but their misuse potential is less well studied and has raised concern.
Yes. The label reports that overdose with zolpidem alone or with other central nervous system depressants has produced impairment of consciousness ranging from drowsiness to coma, cardiovascular or respiratory compromise, and deaths. MedlinePlus’s signs are drowsiness, coma, and slowed breathing or heartbeat. If someone has collapsed, had a seizure, has trouble breathing or cannot be woken, call 911. For a mental-health crisis call or text 988.
MedlinePlus lists shakiness, lightheadedness, stomach and muscle cramps, nausea, vomiting, sweating, flushing, tiredness, uncontrollable crying, nervousness, panic attack, trouble sleeping, uncontrollable shaking, and, rarely, seizures. The label describes the class syndrome as ranging from mild dysphoria and insomnia to cramps, vomiting, sweating, tremors, convulsions and delirium. Do not stop without talking to your doctor. If someone is having a seizure, call 911. For a mental-health crisis call or text 988.
The label gives a mean elimination half-life of about 2.5 hours, with a range of 1.4 to 4.5 hours in the study it reports. That is a property of the drug, not a test window. Zolpidem is not among the nine analyte groups in the federal workplace testing rule and has no row in SAMHSA’s urine detection table, so this page prints no urine, blood or hair window. Specialized tests exist; ask the program or employer what it uses.
NIDA says people dependent on central nervous system depressants should not stop on their own and should undergo medically supervised detoxification, because the amount has to be reduced gradually and withdrawal can be severe. MedlinePlus says not to stop zolpidem without talking to your doctor, especially after longer use. Whether that means a detox admission or a supervised outpatient plan is an assessment decision, and no schedule for it is on this page.
This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Get cost-effective, quality addiction care that truly works.
Start Your Recovery